Come up with a name for your new list and we'll add to it:
AurKa Pharma was acquired by
Eli Lilly & Co. on May 14, 2018.
AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Ventures VII. To date, the biopharmaceutical asset has …